Cite
HARVARD Citation
Cohan, S. et al. (2019). Reducing return of disease activity in patients with relapsing multiple sclerosis transitioned from natalizumab to teriflunomide: 12-month interim results of teriflunomide therapy. Multiple sclerosis journal, experimental, translational and clinical. 5 (1), p. . [Online].